Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Moderna testing 2 booster shots to protect against Omicron variant, expects data soon
US-based pharmaceutical giant Moderna is studying two booster shot options designed to anticipate mutations similar to the Omicron strain of the coronavirus, which has been designated as a variant of concern by the WHO. It is already working to test the ability of the current vaccine dose to neutralise the Omicron variant and data is expected in the coming weeks. “Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant,” the company said in a statement. The first candidate (mRNA-1273.211) includes several mutations present in the Omicron variant that were also present in the Beta variant of concern1. Moderna said it has completed dosing in a potentially pivotal safety and immunogenicity study of mRNA-1273.211 at the 50 µg (N=300) and 100 µg (N=584) dose levels. ALSO READ | PM Modi chairs key meet on Covid-19, vaccination status amid concerns over Omicron variant ...
Comments
Post a Comment